By Small Hours · Last reviewed

Sleep trouble is common in the years around the final period, and research links it to the menopausal transition itself, not only to getting older. A review of the field puts about one woman in four at a level severe enough, and disruptive enough by day, to qualify as insomnia. [1]
What the research says
Sleep trouble tracks the transition itself, not just age. A 2018 review puts 26% of women at sleep difficulty severe enough to affect their days, and long-term studies tie it to menopausal stage and to changes in estrogen and follicle-stimulating hormone, over and above age. [1] In a survey of 982 women aged 35 to 65, chronic insomnia symptoms were reported by 36.5% before menopause, 56.6% during perimenopause and 50.7% after, with severe hot flashes strongly linked to insomnia. [2] The SWAN study, following women year by year, found the odds of trouble falling and staying asleep rose through the transition, and more frequent hot flashes went with every kind of sleep trouble measured. [3] In a sleep-lab follow-up of 159 women, those who reached postmenopause showed more fast brain-wave activity in non-REM sleep, read as a more alert nervous system and not explained by their reported hot flashes; total sleep and time awake did not differ. [4] In plain terms, midlife sleep trouble is common, hormonal, and only partly about the heat.
The studies behind this
- Baker review (2018): 26% of women report severe sleep difficulty that affects daytime functioning. Long-term population studies tie sleep problems to menopausal stage and to changes in the hormones estrogen and follicle-stimulating hormone, over and above the effect of age. [1]
- Ohayon survey (2006): among 982 women aged 35 to 65, chronic insomnia symptoms were reported by 36.5% before menopause, 56.6% in perimenopause and 50.7% after menopause. Severe hot flashes were strongly linked to chronic insomnia. [2]
- SWAN study (Kravitz, 2008): followed women year by year through the transition. The odds of trouble falling asleep and staying asleep rose as women moved through it, and more frequent hot flashes went with more sleep trouble of every kind measured. [3]
- Sleep-lab follow-up (Matthews, 2021): 159 women were recorded overnight about 3.5 years apart. Women who passed into postmenopause showed more fast brain-wave activity during non-REM sleep, which the authors read as a sign of physiological hyperarousal (a more alert nervous system). Hot flashes reported by the women did not explain this. Total sleep time and time awake after falling asleep did not differ between groups. [4]
Why does sleep change?
Researchers describe several overlapping contributors rather than one cause. [1]
- Hot flashes and night sweats. Many, though not all, hot flashes line up with awakenings recorded in a sleep lab. Time awake because of hot flashes adds a meaningful share of the total time awake at night. [1] We cover this in hot flashes and night sweats, and the second-half-of-the-night pattern in waking at 3 a.m. in perimenopause.
- A more alert nervous system. The lab finding above points to something happening in the brain itself, separate from hot flashes. [4]
- Mood. Depression and anxiety symptoms can come with sleep trouble, and some sleep complaints at this stage are really tied to a depressive disorder. [1]
- Other sleep conditions. Sleep-disordered breathing (including sleep apnea) and movement disorders become more common, especially after menopause. [1]
Is it the hormones or just age?
Both play a part, and studies try to separate them. In the SWAN study, falling estrogen levels went with more trouble falling and staying asleep. [3] The Baker review reports that sleep difficulties track menopausal stage over and above age. [1] A Wisconsin study of 589 women found that sleep-disordered breathing was more likely after menopause: the odds of five or more breathing events an hour were 2.6 times those of premenopausal women, after accounting for age, body size and smoking. [5] For what changes with age on its own, see sleep and getting older.
Does the insomnia show up in a sleep lab, or is it only perception?
In a study of 72 women aged 43 to 57, those who had developed insomnia with the menopausal transition slept on average 43.5 minutes less on a laboratory recording than those who had not, and almost half of the sample slept under six hours. [6] So the sleep loss is measurable. It is not only a feeling.
What helps?
- CBT-I (cognitive behavioural therapy for insomnia, a structured treatment that changes the habits and thinking that keep insomnia going). Major guidelines name it the first treatment for chronic insomnia. [7][8] In one trial of women with hot flashes, telephone CBT-I improved insomnia scores more than a menopause-education control did. [9] In a pooled analysis of four trials, each treatment measured against its own control, CBT-I had the largest effect on insomnia scores of the seven compared, which included hormone therapy, two antidepressant-type medicines, exercise, yoga and a supplement. [10] See does CBT-I work for menopause insomnia for the numbers, and what is CBT-I for the basics.
- Menopausal hormone therapy (estrogen, with a progestogen for women who have a uterus). The North American Menopause Society, now called The Menopause Society, says hormone therapy is the most effective treatment for hot flashes and night sweats. It says the risks differ with type, dose, duration, route, timing and whether a progestogen is used, and that for women under 60 or within 10 years of menopause onset with no contraindications the balance of benefit and risk is favourable for bothersome symptoms. [11] Whether it is right for you is a decision for you and your doctor.
- Non-hormonal options. The same society's 2023 statement recommends, for hot flashes and night sweats, cognitive behavioural therapy, clinical hypnosis, certain antidepressants (SSRIs and SNRIs), gabapentin, oxybutynin and fezolinetant. [12] Fezolinetant is approved in Canada under the brand name Veozah. [13] The statement does not recommend dietary supplements or herbal remedies, paced breathing, or several other approaches, because the evidence for reducing hot flashes did not support them. [12] Ask your doctor or pharmacist what applies to you.
We do not recommend or advise against any treatment for an individual here, and nothing on this page is a reason to start, stop or change a medicine without talking to your doctor.
When to see a doctor
- Loud snoring, breathing pauses or sleepiness in the day. The Wisconsin study's authors say evaluation for sleep-disordered breathing should be a priority for menopausal women with snoring, daytime sleepiness or unsatisfactory sleep. [5]
- Low mood or anxiety that is hard to shake. Mood problems and sleep problems can feed each other. [1]
- Poor health or chronic pain. In the Ohayon survey these, along with sleep apnea, were linked to chronic insomnia independently of hot flashes. [2]
Where evidence is thinner
- Most of the large studies are observational, so they show links, not proof of cause. [2][3]
- Self-reported and lab-measured sleep do not always agree. In the lab follow-up, time awake did not change with menopausal status, while the surveys that rely on self-report find more sleep trouble. [4]
- Not every hot flash wakes a person, and not every awakening involves a hot flash. [1]
- Some sleep difficulties differed by ethnic group in the SWAN study, so one pattern may not fit everyone. [3]
Where does this leave you?
Sleep that changes in midlife is real, measurable and treatable. The aim is a clearer day, not a perfect night. Small Hours turns a nightly sleep diary into a plan built around your own sleep. You can sign up at trysmallhours.com.
General education, not medical advice.
References
- Baker FC, de Zambotti M, Colrain IM, Bei B. Sleep problems during the menopausal transition: prevalence, impact, and management challenges. Nat Sci Sleep. 2018;10:73-95. Source for reference 1 (opens in a new tab)
- Ohayon MM. Severe hot flashes are associated with chronic insomnia. Arch Intern Med. 2006;166(12):1262-1268. Source for reference 2 (opens in a new tab)
- Kravitz HM, Zhao X, Bromberger JT, et al. Sleep disturbance during the menopausal transition in a multi-ethnic community sample of women. Sleep. 2008;31(7):979-990. Source for reference 3 (opens in a new tab)
- Matthews KA, Lee L, Kravitz HM, et al. Influence of the menopausal transition on polysomnographic sleep characteristics: a longitudinal analysis. Sleep. 2021;44(11):zsab139. Source for reference 4 (opens in a new tab)
- Young T, Finn L, Austin D, Peterson A. Menopausal status and sleep-disordered breathing in the Wisconsin Sleep Cohort Study. Am J Respir Crit Care Med. 2003;167(9):1181-1185. Source for reference 5 (opens in a new tab)
- Baker FC, Willoughby AR, Sassoon SA, Colrain IM, de Zambotti M. Insomnia in women approaching menopause: beyond perception. Psychoneuroendocrinology. 2015;60:96-104. Source for reference 6 (opens in a new tab)
- Qaseem A, Kansagara D, Forciea MA, Cooke M, Denberg TD. Management of chronic insomnia disorder in adults: a clinical practice guideline from the American College of Physicians. Ann Intern Med. 2016;165(2):125-133. Source for reference 7 (opens in a new tab)
- Riemann D, Espie CA, Altena E, et al. The European Insomnia Guideline: an update on the diagnosis and treatment of insomnia 2023. J Sleep Res. 2023;32(6):e14035. Source for reference 8 (opens in a new tab)
- McCurry SM, Guthrie KA, Morin CM, et al. Telephone-based cognitive behavioral therapy for insomnia in perimenopausal and postmenopausal women with vasomotor symptoms: a MsFLASH randomized clinical trial. JAMA Intern Med. 2016;176(7):913-920. Source for reference 9 (opens in a new tab)
- Guthrie KA, Larson JC, Ensrud KE, et al. Effects of pharmacologic and nonpharmacologic interventions on insomnia symptoms and self-reported sleep quality in women with hot flashes: a pooled analysis of individual participant data from four MsFLASH trials. Sleep. 2018;41(1):zsx190. Source for reference 10 (opens in a new tab)
- The 2022 hormone therapy position statement of The North American Menopause Society. Menopause. 2022;29(7):767-794. Source for reference 11 (opens in a new tab)
- The 2023 nonhormone therapy position statement of The North American Menopause Society. Menopause. 2023;30(6):573-590. Source for reference 12 (opens in a new tab)
- Health Canada. Drug Product Database: Veozah (fezolinetant), DIN 02553600, Astellas Pharma Canada Inc. Accessed 7 October 2026. Source for reference 13 (opens in a new tab)
This article is general education, not medical advice. It cannot diagnose anything or replace a conversation with your doctor. Read how we choose and check sources on the how we write page.